Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine

NCT: NCT05858801 · ACTIVE_NOT_RECRUITING

NCT IDNCT05858801
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-09
Completion2026-12-31

Brief Summary

The purpose of this study is to demonstrate the safe use of the PRIMUS system in subjects with chronic migraine. This is a single-center, open label, prospective, early feasibility study to collect initial clinical data on the PRIMUS system for the treatment of chronic migraine.

Frequently Asked Questions

What is First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine?

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine is a clinical trial registered under NCT05858801. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05858801?

The current status of NCT05858801 (First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine) is: ACTIVE_NOT_RECRUITING.

When did First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine start?

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine started on 2023-05-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑